NIMUL PLUS Tablets – Nimesulide 100 mg + Paracetamol 325 mg

NIMUL PLUS Tablets contain Nimesulide B.P. 100 mg and Paracetamol I.P. 325 mg per uncoated tablet, as specified on the product artwork you provided. The artwork shows a 6 × 5 × 10 Tablets pack.

Nimesulide is an NSAID with analgesic and anti-inflammatory activity, while paracetamol provides analgesic and antipyretic activity. Because nimesulide has important liver-safety considerations, this product should be positioned and used strictly according to the applicable Indian regulatory approval and prescribing information.

---

Composition of NIMUL PLUS Tablets

Product Information

---

What are NIMUL PLUS Tablets Used For?

NIMUL PLUS combines an NSAID (Nimesulide) with Paracetamol, providing analgesic and antipyretic effects.

The formulation may be prescribed for short-term symptomatic management of acute pain and fever when the combination is considered appropriate by the treating healthcare professional.

Depending on the approved indication and physician assessment, it may be considered for:

• Acute painful conditions
• Musculoskeletal pain
• Joint-related pain
• Pain associated with inflammation
• Dental pain
• Pain associated with minor injuries
• Fever associated with painful conditions
• Other acute pain conditions as determined by the physician

Nimesulide is an NSAID used for pain and inflammatory symptoms, while paracetamol is an analgesic and antipyretic. European regulators have specifically emphasized restricting systemic nimesulide because of its liver-injury risk and limiting its use to appropriate short-term indications.

NIMUL PLUS should not be presented as a general long-term painkiller or as a treatment for the underlying cause of chronic joint disease.

---

How Does NIMUL PLUS Work?

NIMUL PLUS contains two active ingredients with complementary analgesic actions.

Nimesulide → Analgesic + Anti-inflammatory action

Paracetamol → Analgesic + Antipyretic action

Combined action:

Pain + Inflammatory symptoms + Fever

↓

Nimesulide + Paracetamol

↓

Reduction in pain, inflammation-related symptoms and fever

---

1. Nimesulide – 100 mg

Nimesulide belongs to the non-steroidal anti-inflammatory drug (NSAID) class.

It acts by reducing the formation of prostaglandins and other mediators involved in pain and inflammation.

Nimesulide provides:

• Analgesic activity
• Anti-inflammatory activity
• Reduction of inflammation-associated pain
• Symptomatic relief of acute painful conditions

Simplified mechanism

Nimesulide → Reduced prostaglandin-mediated inflammatory activity → Reduced pain and inflammation

Nimesulide has been evaluated by regulatory authorities for acute pain and inflammatory conditions, but it carries particular hepatic safety concerns compared with several other NSAIDs.

---

2. Paracetamol – 325 mg

Paracetamol, also known as acetaminophen, is an analgesic and antipyretic medicine.

It provides additional pain-relieving activity and helps reduce fever.

Paracetamol provides:

• Analgesic activity
• Antipyretic activity
• Additional pain control

Simplified action

Paracetamol → Analgesic/antipyretic effect → Reduced pain and fever

---

Combined Action of NIMUL PLUS

Overall formulation

Nimesulide

→ Anti-inflammatory + analgesic activity

Paracetamol

→ Additional analgesic + antipyretic activity

Therefore:

NIMUL PLUS → Combined analgesic and antipyretic/anti-inflammatory symptomatic action

---

Therapeutic Benefits / Role of NIMUL PLUS

1. Pain Relief

Nimesulide and paracetamol provide complementary analgesic activity for selected acute painful conditions.

2. Anti-inflammatory Support

Nimesulide provides anti-inflammatory activity and may help reduce inflammation-associated pain.

3. Fever Reduction

Paracetamol provides antipyretic activity and contributes to fever reduction.

4. Acute Pain Management

The combination may be prescribed for selected short-term acute painful conditions.

5. Dual-Action Analgesic Formulation

NIMUL PLUS combines an NSAID with an analgesic/antipyretic in one tablet.

---

Common Clinical Applications

1. Acute Musculoskeletal Pain

Musculoskeletal conditions may produce:

• Pain
• Tenderness
• Inflammation
• Stiffness
• Reduced movement

NIMUL PLUS may be prescribed for short-term symptomatic management when considered appropriate.

---

2. Joint-Related Pain

Inflammatory joint conditions can cause pain and stiffness.

Nimesulide provides anti-inflammatory and analgesic activity, while paracetamol provides additional analgesic activity.

However, NIMUL PLUS should not be promoted as a cure for arthritis or permanent joint damage.

---

3. Dental Pain

Dental conditions and dental procedures may result in acute pain and inflammatory symptoms.

An appropriate analgesic may be prescribed for short-term symptomatic management.

---

4. Acute Injury-Related Pain

Minor injuries may result in pain and inflammatory symptoms.

NIMUL PLUS may be prescribed when an NSAID-based analgesic approach is considered appropriate.

---

5. Fever With Pain

Paracetamol provides antipyretic activity and may help reduce fever when fever accompanies a painful condition.

---

Suggested Use

NIMUL PLUS Tablets should be taken strictly according to the prescription of a qualified healthcare professional.

The appropriate dosage and treatment duration depend on:

• Patient age
• Type and severity of pain
• Medical history
• Liver function
• Kidney function
• Other medicines being taken
• Risk factors for NSAID-related adverse effects

Because the product artwork does not specify a dosage schedule, an exact number of tablets per day should not be invented for the website.

Administration

• Take orally with water.
• Follow the physician’s prescribed dosage.
• Use only for the duration recommended by the physician.
• Do not exceed the prescribed dose.
• Do not take additional paracetamol-containing medicines without checking the total daily intake.
• Do not combine with another NSAID unless specifically advised.

---

Important Duration-of-Treatment Consideration

Nimesulide requires particular attention to duration of treatment because of its hepatic safety profile.

The EMA previously concluded that systemic nimesulide should be restricted to short-term use, with a maximum treatment duration of 15 days under its European regulatory framework.

For your Indian product page, however, the exact duration should be stated according to the approved Indian prescribing information for NIMUL PLUS, rather than automatically copying the European restriction.

---

Possible Side Effects

Possible adverse effects may include:

Gastrointestinal

• Nausea
• Vomiting
• Indigestion
• Abdominal discomfort
• Diarrhea
• Gastric irritation
• Heartburn

Nervous System

• Headache
• Dizziness
• Drowsiness

Other

• Skin rash
• Allergic reactions
• Changes in liver enzymes

Individual response varies.

---

Important Serious Side Effects

NIMUL PLUS contains nimesulide, which has an important hepatotoxicity/liver-injury warning profile.

Potential serious adverse reactions may include:

• Liver injury
• Significant elevation of liver enzymes
• Gastrointestinal bleeding
• Peptic ulceration
• Kidney injury
• Severe allergic reactions
• Severe skin reactions

Nimesulide has been associated with a higher liver-toxicity concern than some other anti-inflammatory treatments, which is why regulatory authorities have imposed restrictions on its systemic use.

---

Precautions & Warnings

1. Liver Precautions

This is the most important precaution for NIMUL PLUS.

Patients with existing liver disease or abnormal liver-function tests should inform their healthcare professional before using the medicine.

Treatment should be stopped and medical advice sought if symptoms suggestive of liver injury occur.

These may include:

• Loss of appetite
• Persistent nausea
• Unusual fatigue
• Abdominal discomfort
• Dark urine
• Yellowing of the skin or eyes

Nimesulide’s liver-safety concerns have been documented by regulatory authorities.

---

2. Gastrointestinal Precautions

Nimesulide, like other NSAIDs, can cause gastrointestinal adverse effects.

Possible complications include:

• Gastritis
• Ulceration
• Gastrointestinal bleeding

Particular caution may be necessary in patients with a previous history of peptic ulcer disease or gastrointestinal bleeding.

---

3. Kidney Precautions

NSAIDs can affect kidney function, particularly in susceptible patients.

Caution may be required in patients with:

• Kidney disease
• Dehydration
• Heart failure
• Older age
• Concomitant medicines affecting kidney function

---

4. Cardiovascular Precautions

NSAIDs may increase cardiovascular risk, particularly with higher doses or prolonged use.

Patients with:

• Heart disease
• High blood pressure
• Previous stroke
• Other cardiovascular risk factors

should discuss use with their healthcare professional.

---

Paracetamol-Related Precaution

NIMUL PLUS contains Paracetamol 325 mg.

Patients should check all other medicines for paracetamol/acetaminophen to prevent accidental excessive intake.

Excessive paracetamol intake can cause serious liver injury.

This is particularly important for NIMUL PLUS because both nimesulide and paracetamol have hepatic safety considerations. CDSCO’s expert review of the nimesulide/paracetamol FDC specifically noted this concern.

---

Drug & Medicine Interactions

Patients should inform their healthcare professional about all prescription medicines, OTC medicines, supplements and herbal products they are taking.

Particular attention may be required with:

• Other NSAIDs
• Aspirin
• Anticoagulants
• Antiplatelet medicines
• Corticosteroids
• Diuretics
• ACE inhibitors
• ARBs
• Medicines affecting kidney function
• Other paracetamol-containing medicines
• Potentially hepatotoxic medicines

Important

Do not combine NIMUL PLUS with another NSAID unless specifically advised by a healthcare professional.

Also check other medicines for paracetamol/acetaminophen.

---

Alcohol

Alcohol should preferably be avoided during treatment unless the treating healthcare professional advises otherwise.

This is especially relevant because both nimesulide and excessive paracetamol exposure can create liver-safety concerns.

---

Pregnancy & Breastfeeding

Pregnant or breastfeeding women should consult their healthcare professional before taking NIMUL PLUS.

NSAID use during pregnancy requires particular consideration, especially later in pregnancy.

The decision to use this combination should be based on the individual clinical situation and applicable prescribing information.

---

Use in Elderly Patients

Older patients may be more susceptible to NSAID-related adverse effects.

Particular attention may be required for:

• Gastrointestinal complications
• Kidney function
• Liver function
• Cardiovascular risk
• Drug interactions

---

Use in Kidney or Liver Disease

Patients with kidney or liver disease should inform their physician before using NIMUL PLUS.

The physician may evaluate:

• Liver function
• Kidney function
• Other medicines
• Existing medical conditions
• Overall risk-benefit profile

before prescribing the medicine.

---

When Should Medical Attention Be Sought?

Patients should seek prompt medical attention if they develop:

• Yellowing of the skin or eyes
• Dark urine
• Severe or persistent nausea
• Unusual fatigue
• Severe abdominal pain
• Black or bloody stools
• Vomiting blood
• Chest pain
• Difficulty breathing
• Facial or throat swelling
• Severe skin rash
• Significant reduction in urine
• Other severe or unusual symptoms

---

Storage

Store NIMUL PLUS Tablets:

• In a cool, dry place
• Away from direct sunlight
• Protected from excessive heat and moisture
• In the original packaging
• Out of reach of children

Follow the storage conditions printed on the final approved product packaging.

---

Key Product Features

---

Why Choose NIMUL PLUS Tablets?

NIMUL PLUS combines:

Nimesulide 100 mg

Provides analgesic and anti-inflammatory activity.

Paracetamol 325 mg

Provides analgesic and antipyretic activity.

Overall formulation:

Pain + Inflammatory symptoms + Fever

→ Nimesulide + Paracetamol

→ Symptomatic analgesic and antipyretic action

The combination should be used only where clinically appropriate and according to the applicable approved product information.